mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |